LITTLE FALLS, N.J., June 29, 2016 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN) is pleased to announce that Chief Executive Officer Andrew Krakauer received the EY Entrepreneur Of The Year 2016 New Jersey Award in the Life Sciences category. This year marks the 30th anniversary of the EY Entrepreneur Of The Year program. The award is given to entrepreneurs who demonstrate exceptional success in areas such as innovation, financial performance and personal commitment to their businesses and communities and were selected by an independent panel of judges. Mr. Krakauer and other regional winners were unveiled at a special gala on June 23, 2016 and are now eligible for the EY Entrepreneur Of The Year National Awards to be presented in November.
Andrew Krakauer, CEO stated, "I am honored to be included in this group of outstanding business leaders. I applaud the judges and EY for recognizing that entrepreneurship is a critical skill needed in successful and growing mid-size public companies such as Cantel. I share this award with our senior management team and nearly 2,000 employees whose work and dedication are the root of our success."
About Cantel Medical
Cantel Medical is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cantel-medical-ceo-andrew-krakauer-named-ey-entrepreneur-of-the-year-2016-new-jersey-region-300292068.html
SOURCE Cantel Medical Corp.